Yiqiao Luo

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ingrid Herr · 6 shared papers, 2019–2022 · strength 0.74
   • Paper UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis. DOI 10.3389/fonc.2022.834647↗
   • Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
   • Paper Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Pr… DOI 10.3390/cancers13040827↗
2. Bin Yan · 4 shared papers, 2021–2022 · strength 0.56
   • Paper UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis. DOI 10.3389/fonc.2022.834647↗
   • Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
   • Paper Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Pr… DOI 10.3390/cancers13040827↗
3. Xuefeng An · 3 shared papers, 2021–2022 · strength 0.38
   • Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
   • Paper Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Pr… DOI 10.3390/cancers13040827↗
   • Paper Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pan… DOI 10.3390/cancers13194770↗
4. Li Liu · 3 shared papers, 2021–2022 · strength 0.38
   • Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
   • Paper Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Pr… DOI 10.3390/cancers13040827↗
   • Paper Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pan… DOI 10.3390/cancers13194770↗
5. Libo Yin · 3 shared papers, 2019–2021 · strength 0.31
   • Paper Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Pr… DOI 10.3390/cancers13040827↗
   • Paper Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer. DOI 10.1016/j.omto.2019.03.011↗
   • Paper MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. DOI 10.1016/j.canlet.2019.03.025↗
6. Lian Zhao · 2 shared papers, 2022 · strength 0.30
   • Paper UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis. DOI 10.3389/fonc.2022.834647↗
   • Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
7. Christina Georgikou · 2 shared papers, 2019 · strength 0.19
   • Paper Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer. DOI 10.1016/j.omto.2019.03.011↗
   • Paper MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. DOI 10.1016/j.canlet.2019.03.025↗
8. Li Liu · 2 shared papers, 2019 · strength 0.19
   • Paper Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer. DOI 10.1016/j.omto.2019.03.011↗
   • Paper MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. DOI 10.1016/j.canlet.2019.03.025↗
9. Xi Xiao · 2 shared papers, 2019 · strength 0.19
   • Paper Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer. DOI 10.1016/j.omto.2019.03.011↗
   • Paper MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. DOI 10.1016/j.canlet.2019.03.025↗
10. Franco Fortunato · 1 shared paper, 2022 · strength 0.13
    • Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
11. Matthias M. Gaida · 1 shared paper, 2022 · strength 0.13
    • Paper Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarci… DOI 10.1016/j.matbio.2022.11.002↗
12. Michael Schaefer · 1 shared paper, 2021 · strength 0.12
    • Paper Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pan… DOI 10.3390/cancers13194770↗
13. Kangtao Wang · 1 shared paper, 2021 · strength 0.12
    • Paper Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pan… DOI 10.3390/cancers13194770↗
14. Svetlana Karakhanova · 1 shared paper, 2019 · strength 0.08
    • Paper MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. DOI 10.1016/j.canlet.2019.03.025↗
15. Yefeng Yin · 1 shared paper, 2019 · strength 0.08
    • Paper MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. DOI 10.1016/j.canlet.2019.03.025↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.